Concert Pharmaceuticals Inc - Lexington, Massachusetts 02421

Concert Pharmaceuticals Inc is categorized under in Lexington, MA .

Business Name: Concert Pharmaceuticals Inc
Contact Person: Roger Tung, Chief Executive Officer
Address: 99 Hayden Avenue # 500, Lexington, Massachusetts 02421
Phone Number: (781) 860-0045
Website Address: concertpharma.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founding Year: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 3254120
Share This Business:
Related Businesses: Nitromed Inc - Lexington, MA 02421
Biousian Biosystems Inc (Bbi) - Lexington, MA 02421
Endo Pharmaceuticals Solutions Incorporated - Lexington, MA 02421
Ledgemont Royalty Sub LLC - Lexington, MA 02421
Novatarg Pharmaceuticals - Lexington, MA 02421
Synerz Pharmaceuticals - Lexington, MA 02421
Pulmatrix Inc - Lexington, MA 02421
Interneuron Pharmaceutical - Lexington, MA 02421
Synta Pharmaceuticals Corp - Lexington, MA 02421
Eyegate Pharmaceuticals - Lexington, MA 02421
Adolor Corporation - Lexington, MA 02421
Shafa Pharmaceuticals Inc - Lexington, MA 02421
Cubist Pharmaceuticals Inc - Lexington, MA 02421
Endo Pharmaceuticals Inc - Lexington, MA 02421

The company Concert Pharmaceuticals Inc provides BOTH services in the form of from its single location in Massachusetts. 1 to 4 employees work for Concert Pharmaceuticals Inc, and the business now earns $5.000.000 to $9.999.999 per annum.

Concert Pharmaceuticals Inc was launched in 2006 and is classified under SIC code and category 2834 , and NAICS number and grouping 3254120 . To contact Concert Pharmaceuticals Inc, please call Roger Tung, Chief Executive Officer with the phone number (781) 860-0045 or visit its single location at 99 Hayden Avenue # 500 in Lexington, Massachusetts 02421.

The location of the single location can also be found using the coordinates 42.424928,-71.250141. Read more details about this business on the webpage concertpharma.com or follow the company’s social media accounts, on Twitter and on Facebook.